These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22811440)

  • 21. Screening for Breast Cancer: What You Need to Know.
    Farrell K; Bennett DL; Schwartz TL
    Mo Med; 2020; 117(2):133-135. PubMed ID: 32308238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation Science Workshop: Barriers and Facilitators to Increasing Mammography Screening Rates in California's Public Hospitals.
    Clarity C; Gourley G; Lyles C; Ackerman S; Handley MA; Schillinger D; Sarkar U; Conigliaro J
    J Gen Intern Med; 2017 Jun; 32(6):697-705. PubMed ID: 28188571
    [No Abstract]   [Full Text] [Related]  

  • 23. Downstream Breast Imaging Following Screening Mammography in Medicare Patients with Advanced Cancer: A Population-Based Study.
    Sadigh G; Duszak R; Ward KC; Jiang R; Switchenko JM; Applegate KE; Carlos RC
    J Gen Intern Med; 2018 Mar; 33(3):284-290. PubMed ID: 29139055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling.
    Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
    Hong Kong Med J; 2010 Jun; 16 Suppl 3():38-41. PubMed ID: 20601733
    [No Abstract]   [Full Text] [Related]  

  • 25. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer?
    Mandelblatt JS; Stout N; Trentham-Dietz A
    Ann Intern Med; 2011 Jul; 155(1):58-60. PubMed ID: 21727294
    [No Abstract]   [Full Text] [Related]  

  • 26. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
    Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
    Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Receipt of Cancer Screening in Medicare Beneficiaries Following the Affordable Care Act.
    Cooper GS; Kou TD; Schluchter MD; Dor A; Koroukian SM
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26640244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overdiagnosis of screen-detected breast cancer.
    Milch V; Aranda S; Canfell K; Varlow M; Roder DM; Currow D; Anderiesz C; Keefe D
    Med J Aust; 2021 Jun; 214(10):455-456.e1. PubMed ID: 33993477
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overdiagnosis of breast cancer at screening is clinically insignificant.
    Feig SA
    Acad Radiol; 2015 Aug; 22(8):961-6. PubMed ID: 25797300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of health benefits and cost-effectiveness of mammography for breast cancer.
    Keen JD
    Ann Intern Med; 2011 Oct; 155(8):566; author reply 566-7. PubMed ID: 22007057
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.
    Tina Shih YC; Dong W; Xu Y; Shen Y
    Value Health; 2019 Feb; 22(2):185-193. PubMed ID: 30711063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lessons from the Swiss Medical Board recommendation against mammography screening programs.
    Chiolero A; Rodondi N
    JAMA Intern Med; 2014 Oct; 174(10):1541-2. PubMed ID: 25154463
    [No Abstract]   [Full Text] [Related]  

  • 35. Summaries for Patients. Screening for Breast Cancer: Recommendations From the U.S. Preventive Services Task Force.
    Ann Intern Med; 2016 Feb; 164(4):. PubMed ID: 26756910
    [No Abstract]   [Full Text] [Related]  

  • 36. Mammogram trials.
    Jha S; Ware JB
    Acad Radiol; 2015 Aug; 22(8):973-5. PubMed ID: 26100196
    [No Abstract]   [Full Text] [Related]  

  • 37. A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women.
    Shen S; Zhou Y; Xu Y; Zhang B; Duan X; Huang R; Li B; Shi Y; Shao Z; Liao H; Jiang J; Shen N; Zhang J; Yu C; Jiang H; Li S; Han S; Ma J; Sun Q
    Br J Cancer; 2015 Mar; 112(6):998-1004. PubMed ID: 25668012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ductal carcinomas in situ and invasive cancers detected on screening mammography: Cost-effectiveness of initial and subsequent rounds of population-based program 2007-2014.
    Szynglarewicz B; Matkowski R
    Adv Clin Exp Med; 2017; 26(2):259-262. PubMed ID: 28791843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast Cancer Screening in Average-Risk Women.
    Ann Intern Med; 2019 Apr; 170(8):. PubMed ID: 30959524
    [No Abstract]   [Full Text] [Related]  

  • 40. Women aged 75 years and older benefit from mammography.
    Printz C
    Cancer; 2015 Jan; 121(2):165. PubMed ID: 25581117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.